Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01543607 · ClinicalTrials.gov registry record · NA
Endoscopic Therapy of Malignant Bile Duct Strictures
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01543607: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT01543607 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01543607, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Patients with malignant bile duct stenosis have poor prognosis and most of the patients are not good candidate for surgery at the time of diagnosis. Placement of the stent is the palliative care for these patients. However over 50% of the stents get blocked within 6-8 months. Use of the radiofrequency ablation before the stent placement may improve stent patency. Heat will be applied to the bile duct in order to open the blockage and prevent the re-growth of tissue into the stent. The investigators are looking to see how safe and feasible RFA (Radiofrequency ablation) catheter is in patient with malignant bile duct stenosis.
Interventions
- DEVICE Radiofrequency ablation catheter (Habib EndoHBP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01543607
The ClinicalTrials.gov registry entry for NCT01543607 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiofrequency ablation catheter (Habib EndoHBP) is the first listed.
NCT01543607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01543607 about?
NCT01543607 is a clinical study titled "Endoscopic Therapy of Malignant Bile Duct Strictures". Patients with malignant bile duct stenosis have poor prognosis and most of the patients are not good candidate for surgery at the time of diagnosis. Placement of the stent is the palliative care for these patients. However over 50% of the stents get blocked within 6-8 months. Use of the radiofrequen...
What is the current status of trial NCT01543607?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2012-02. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01543607?
The interventions under investigation include: Radiofrequency ablation catheter (Habib EndoHBP) (DEVICE).
Who is sponsoring clinical trial NCT01543607?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.